feed,title,long_url,short_url
Benzinga,"Cerecor Appoints Gilla Kaplan, Ph.D., to the Board of Directors",https://www.benzinga.com/pressreleases/20/10/g17866459/cerecor-appoints-gilla-kaplan-ph-d-to-the-board-of-directors,https://j.mp/2IiYSax
Benzinga,Ovid Therapeutics to Present at the Child Neurology Society/International Child Neurology Association (CNS/ICNA) Virtual Congress,https://www.benzinga.com/pressreleases/20/10/g17866456/ovid-therapeutics-to-present-at-the-child-neurology-societyinternational-child-neurology-associati,https://j.mp/31eFnH1
Benzinga,Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics,https://www.benzinga.com/pressreleases/20/10/g17866454/sunesis-pharmaceuticals-announces-presentation-of-sns-510-preclinical-data-at-the-32nd-eortc-nci-a,https://j.mp/30XBCWi
Benzinga,Mesa Air Group Reports September 2020 Operating Performance,https://www.benzinga.com/pressreleases/20/10/g17866453/mesa-air-group-reports-september-2020-operating-performance,https://j.mp/34SzPme
Benzinga,Amicus Therapeutics Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 49th Annual Meeting of the Child Neurology Society,https://www.benzinga.com/pressreleases/20/10/g17866452/amicus-therapeutics-announces-additional-positive-interim-clinical-data-for-cln6-batten-disease-ge,https://j.mp/33OsdC0
Benzinga,"Parsons Mitigating Zero-Day Cyber Attacks, Wins SharkSeer 2.0",https://www.benzinga.com/pressreleases/20/10/n17866432/parsons-mitigating-zero-day-cyber-attacks-wins-sharkseer-2-0,https://j.mp/3nEjM45
